Funding for this research was provided by:
Ministry of Education - Singapore (MOE2019-T2-1-115)
National Research Foundation Singapore (NRF-CRP-2017-05)
Received: 12 January 2020
Accepted: 16 May 2020
First Online: 22 May 2020
Ethics approval and consent to participate
: Bone marrow mononuclear cells (BMMNCs) from healthy donors were obtained from CSI Epigenomics Core provided by Dr. Wilson Wang. All animal studies were performed in accordance with animal research protocols approved by the National University of Singapore Institutional Animal Care and Use Committee, Singapore.
: Not applicable.
: EK.-H.C is a co-founder and shareholder of KYAN Therapeutics.